These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26842877)

  • 41. Calreticulin as a marker and therapeutic target for cancer.
    Zhang M; Xiao J; Liu J; Bai X; Zeng X; Zhang Z; Liu F
    Clin Exp Med; 2023 Sep; 23(5):1393-1404. PubMed ID: 36335525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 7, 8-diacetoxy-4-methylcoumarin induced cell death in human tumor cells is influenced by calreticulin.
    Verma A; Bhatt AN; Farooque A; Khanna S; Khaitan D; Arya MB; Arya A; Dhawan A; Raj HG; Saluja D; Prasad AK; Parmar VS; Dwarakanath BS
    Biochimie; 2011 Mar; 93(3):497-505. PubMed ID: 21075165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
    Su YJ; Ren K; Li H; Ren XB; Wang CL
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.
    Cheng WF; Hung CF; Chai CY; Hsu KF; He L; Ling M; Wu TC
    J Clin Invest; 2001 Sep; 108(5):669-78. PubMed ID: 11544272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
    Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
    Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
    Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
    J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
    Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
    Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
    Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
    Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
    Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ecto-calreticulin in immunogenic chemotherapy.
    Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
    Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calreticulin translocation aggravates endoplasmic reticulum stress-associated apoptosis during cardiomyocyte hypoxia/reoxygenation.
    Xu FF; Liu XH
    Chin Med J (Engl); 2015 Feb; 128(3):353-60. PubMed ID: 25635431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
    Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
    J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer.
    Sterlacci W; Wolf D; Savic S; Hilbe W; Schmid T; Jamnig H; Fiegl M; Tzankov A
    Hum Pathol; 2012 Mar; 43(3):339-49. PubMed ID: 21840566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity.
    Cheng WF; Lee CN; Su YN; Chai CY; Chang MC; Polo JM; Hung CF; Wu TC; Hsieh CY; Chen CA
    Cancer Gene Ther; 2006 Sep; 13(9):873-85. PubMed ID: 16645621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells.
    Abdullah TM; Whatmore J; Bremer E; Slibinskas R; Michalak M; Eggleton P
    Cancer Immunol Immunother; 2022 Jul; 71(7):1655-1669. PubMed ID: 34800147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.